Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Ann Surg Oncol. 2013 Dec 10;21(4):1159–1165. doi: 10.1245/s10434-013-3358-y

FIG. 1.

FIG. 1

a Kaplan–Meier overall survival curve for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (n = 65). Median overall survival was 46.2 months, with 1-, 2-, and 5-year overall survival probability of 77, 57, and 39 %, respectively. b Kaplan–Meier curve for time to progression for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (n = 54). Median progression-free survival was 13.9 months, with 1-, 2-, and 5-year disease failure probability of 47, 68, and 83 %, respectively